A phase II study of carboplatin AUC-10 guided by positron emission tomography-defined metabolic response in metastatic seminoma.

A phase II study of carboplatin AUC-10 guided by positron emission tomography-defined metabolic response in metastatic seminoma. Eur J Cancer. 2019 07; 115:128-135.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Agents
Carboplatin
Clinical Decision-Making
Disease Progression
Humans
London
Male
Middle Aged
Neoplasm Staging
Positron Emission Tomography Computed Tomography
Predictive Value of Tests
Risk Assessment
Risk Factors
Seminoma
Testicular Neoplasms
Time Factors
Young Adult

authors with profiles

Anand K Sharma